Ligand profile
ZINC7917230
Virtual-screening candidate from ZINC.
Bound to: KP13_04919 — 3-oxoacyl-[acyl-carrier-protein] reductase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC7917230- UniProt (similar protein)
O54438- Tanimoto
- 0.833
- Target protein
- KP13_04919
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 34.0
- −1 ≤ LogP ≤ 5 3.74
- MW ≤ 500 Da 264.3
- LogP ≤ 5 3.74
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 34.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1ccc(NC(=O)c2cn(C)c3ccccc23)cc1Cc1ccc(NC(=O)c2cn(C)c3ccccc23)cc1
InChI=1S/C17H16N2O/c1-12-7-9-13(10-8-12)18-17(20)15-11-19(2)16-6-4-3-5-14(15)16/h3-11H,1-2H3,(H,18,20)InChI=1S/C17H16N2O/c1-12-7-9-13(10-8-12)18-17(20)15-11-19(2)16-6-4-3-5-14(15)16/h3-11H,1-2H3,(H,18,20)
WHLBLGACZITNTL-UHFFFAOYSA-NWHLBLGACZITNTL-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- 8M5
- Homolog
- O54438
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC7917230 →
- ZINC ZINC20 ZINC7917230 →
- UniProt UniProt O54438 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC7917230”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_04919.
PDB 18
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 5
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).